Introduction: Allogeneic hematopoietic stem cell transplantation (HSCT) is an established
treatment of myeloid and lymphoid malignancies, solid tumors and a number of metabolic …

Hematopoietic stem cell transplantation (HSCT) is commonly used as a curative therapy for
both malignant and non-malignant pediatric hematological diseases. Despite development …

Purpose This review offers an informed insight on the pathophysiology of ocular graft-versus-
host disease in addition to up-to-date recommendations for monitoring and management …

Hematopoietic stem cell transplantation is important in the management of several
lymphoproliferative and bone marrow disorders. Graft-versus-host disease (GVHD) involves …

Purpose: To identify risk factors for ocular graft-versus-host disease (oGVHD) in children
with graft-versus-host disease (GVHD). Methods: This retrospective cohort study identified …

Current insights into ocular graft-versus-host disease : Current Opinion in Ophthalmology
Current insights into ocular graft-versus-host disease : Current Opinion in Ophthalmology Log …

Ocular graft-versus-host disease (oGVHD) contributes substantially to morbidity after
allogeneic haematopoietic stem cell transplantation (HSCT) but is sparsely investigated in …

Graft-versus-host disease (GVHD) is a common cause of morbidity and mortality after
allogeneic hematopoietic stem cell transplantation. Systemic findings involving the skin …

Graft-versus-host disease (GVHD) is a major complication that occurs following allogeneic
hematopoietic stem cell transplantation, which is a potential curative therapy used in a …

Ocular graft-versus-host disease (GVHD) occurs in more than half of patients who develop
chronic GVHD after allogeneic hematopoietic cell transplantation (HCT), causing prolonged …